Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.
Oncotarget 2017 Feb .
Kuo Sung-Hsin, Yang Shi-Yi, You San-Lin, Lien Huang-Chun, Lin Ching-Hung, Lin Po-Han, Huang Chiun-She
S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.
International journal of clinical and experimental pathology 2015 8 (5): 5309-17.
Shao Xiying, Cai Jinwei, Zheng Yabing, Wang Jiwen, Feng Jianguo, Huang Yuan, Shi Lei, Chen Zhanhong, Guo Yong, Wang Xiaoj